Columnist Dagmar Munn says she has often felt out of place in the ALS community because of the slower pace of her disease ...
Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
IEEE Spectrum on MSN22h
New Brain Tech Gives Voice to ALS PatientsA myotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects muscle control, and most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback